Pharmaceuticals in surface waters: sources, behavior, ecological risk, and possible solutions. Case study of Lake Geneva, Switzerland

Wiley Interdisciplinary Reviews: Water

Volumn 1, Issue 1, 2014, Pages 69-86

  Chèvre, Nathalie ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84920277090     PISSN: None     EISSN: 20491948     Source Type: Journal    
DOI: 10.1002/wat2.1006     Document Type: Review

References (89)

1. Halling-Sørensen B, Nielsen SN, Lanzky P, Ingerslev F, Holten Lützhøft H-C, Jørgensen SE. Occurrence, fate and effects of pharmaceutical substances in the environment—a review. Chemosphere 1998, 36:357–393.
2. Brooks BW, Huggett DB, Boxall ABA. Pharmaceuticals and personal care products: research needs for the next decade. Environ Toxicol Chem 2009, 28:2469–2472.
3. Williams RT. Human Pharmaceuticals: Assessing the Impacts on Aquatic Systems. Pensacola, FL: SETAC Press; 2005.
4. Zuccato E, Castiglioni S, Fanelli R, Reitano G, Bagnati R, Chiabrando C, Pomati F, Rossetti C, Calamari D. Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control. Environ Sci Pollut Res 2006, 13:15–21.
5. Kümmerer K. The presence of pharmaceuticals in the environment due to human use—present knowledge and future challenges. J Environ Manage 2009, 90:2354–2366.
6. Bruce G, Pleus R, Snyder SA. Toxicological relevance of pharmaceuticals in drinking water. Environ Sci Tech 2010, 44:5619–5626.
7. Chèvre N, Maillard E, Loepfe C, Becker-van Slooten K. Determination of water quality standards for chemical mixtures: extension of a methodology developed for herbicides to a group of insecticides and to a group of pharmaceuticals. Ecotoxicol Environ Saf 2008, 71:740–748.
8. Poté J, Haller L, Loizeau J-L, Garcia Bravo A, Sastre V, Wildi W. Effects of a sewage treatment plant outlet pipe extension on the distribution of contaminants in the sediments of the Bay of Vidy, Lake Geneva, Switzerland. Bioresour Technol 2008, 99:7122–7131.
9. Kümmerer K. Pharmaceuticals in the environment: sources, fate, effects and risks. Springer: Berlin, Heidelberg; 2004.
10. Ternes T, Joss A. Human Pharmaceuticals, Hormones and Fragrances. The Challenge of Micropollutants in Urban Water Management. London: IWA Publishing; 2006.
11. Edder P, Ortelli D, Ramseier S. Métaux et micropolluants organiques dans les rivières et les eaux du Léman. Rapport de la Commission internationale pour la protection des eaux du Léman contre la pollution 2006; Campagne 2005, 65–87.
12. Verlicchi P, Al Aukidy M, Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment—A review. Sci Tot Environ 2012, 429:123–155.
13. Morasch B, Bonvin F, Reiser H, Grandjean D, de Alencastro LF, Perazzolo C, Chèvre N, Kohn T. Prioritization, occurrence and fate of micropollutants in the Vidy bay (Lake Geneva), part II: micropollutant removal in the wastewater treatment plant and during subsequent passage through the bay into raw drinking water. Environ Toxicol Chem 2010, 29:1658–1668.
14. Perazzolo C, Morasch B, Kohn T, Magnet A, Thonney D, Chèvre N. Prioritization occurrence and fate of micropollutants in the Vidy bay (Lake Geneva): part I: establishment of a priority list for environmental risk assessment. Environ Toxicol Chem 2010, 29:1649–1657.
15. Coutu S, Rossi L, Rudaz S, Andrew B, Vernaz N. Temporal variability of antibiotics fluxes in wastewater and contribution from hospitals. PLoS One 2013, 8:e53592.
16. Langford K, Thomas KV. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ Int 2009, 35:766–770.
17. Verlicchi P, Al Aukidy M, Galletti A, Petrovic M, Barceló D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci Tot Environ 2012, 430:109–118.
18. Weyrauch P, Matzinger A, Pawlowsky-Reusing E, Plume S, von Seggern D, Heinzmann B, Schroeder K, Rouault P. Contribution of combined sewer overflows to trace contaminant loads in urban streams. Water Res 2010, 44:4451–4462.
19. Wolf L, Zwiener C, Zemann M. Tracking artificial sweeteners and pharmaceuticals introduced into urban groundwater by leaking sewer networks. Sci Tot Environ 2012, 430:8–19.
20. Chèvre N, Coutu S, Margot J, Wynn HK, Bader HP, Scheidegger R, Rossi L. Substance flow analysis as a tool for mitigating the impact of pharmaceuticals on the aquatic system. Water Res 2013, 47:2995–3005.
21. Al Aukidy M, Verlicchi P, Jelic A, Petrovic M, Barcelò D. Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy. Sci Tot Environ 2012, 438:15–25.
22. Boxall A, Fogg L, Kay P, Blackwell P, Pemberton E, Croxford A. Veterinary medicines in the environment. Rev Environ Contam Toxicol 2004, 180:1–91.
23. Kummerer K. Antibiotics in the aquatic environment—a review—Part I. Chemosphere 2009, 75:417–434.
24. Menetrey N, Oertli B, Sartori M, Wagner A, Lachavanne J. Eutrophication: are mayflies (Ephemeroptera) good bioindicators for ponds? Hydrobiologia 2008, 597:125–135.
25. Hamscher G, Pawelzick H, Hoper H, Nau H. Different behavior of tetracyclines and sulfonamides in sandy soils after repeated fertilization with liquid manure. Environ Toxicol Chem 2005, 24:861–868.
26. Stoob K. Veterinary sulfonamide antibiotics in the environment: fate in grassland soils and transport to surface waters. PhD dissertation, eawag, 2005.
27. Reinert KH, Giddings JM, Judd L. Effects analysis of time-varying or repeated exposures in aquatic ecological risk assessment of agrochemicals. Environ Toxicol Chem 2002, 21:1977–1992.
28. Boxall ABA, Fogg LA, Ashauer R, Bowles T, Sinclair CJ, Colyer A, Brain RA. Effects of repeated pulsed herbicide exposures on the growth of aquatic macrophytes. Environ Toxicol Chem 2013, 32:193–200.
29. Bartelt-Hunt S, Snow D, Damon-Powell T, Miesbach D. Occurrence of steroid hormones and antibiotics in shallow groundwater impacted by livestock waste control facilities. J Contam Hydrol 2010, 123:94–103.
30. Hu X, Zhou Q, Luo Y. Occurrence and source analysis of typical veterinary antibiotics in manure, soil, vegetables and groundwater from organic vegetable bases, northern China. Environ Pollut 2010, 158:2992–2998.
31. Kools SA, Boxall AB, Moltmann JF, Bryning G, Koschorreck J, Knacker T. A ranking of European veterinary medicines based on environmental risks. Integr Environ Assess Manag 2008, 4:399–408.
32. Bernard M, Arnold C. Micropolluants dans les eaux du Rhône. Rapport de la Commission internationale pour la protection des eaux du Léman contre la pollution 2009; Campagne 2008, 145–155.
33. Ortelli D, Edder P, Klein A, Ramseier Gentile S. Métaux et micropolluants organiques dans les eaux du Léman. Rapport de la Commission internationale pour la protection des eaux du Léman contre la pollution 2012; Campagne 2011, 51–66.
34. Ortelli D, Edder P, Rapin F, Ramseier S. Métaux et micropolluants organiques dans les rivières et les eaux du Léman. Rapport de la Commission internationale pour la protection des eaux du Léman contre la pollution 2010; Campagne 2009, 57–76.
35. Edder P, Ortelli D, Ramseier S, Chèvre N. Métaux et micropolluants organiques dans les eaux du Léman. Rapport de la Commission internationale pour la protection des eaux du Léman contre la pollution 2007; Campagne 2006, 59–81.
36. Focazio MJ, Kolpin DW, Barnes KK, Furlong ET, Meyer MT, Zaugg SD, Barber LB, Thurman ME. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States—II) Untreated drinking water sources. Sci Tot Environ 2008, 402:201–216.
37. Weigel S, Berger U, Jensen E, Kallenborn R, Thoresen H, Hühnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583–592.
38. Ort C, Hollender J, Schaerer M, Siegrist H. Model-based evaluation of reduction strategies for micropollutants from wastewater treatment plants in complex river networks. Environ Sci Technol 2009, 43:3214–3220.
39. Bonvin F, Rutler R, Chèvre N, Halder J, Kohn T. Spatial and temporal presence of a wastewater-derived micropollutant plume in lake Geneva. Environ Sci Tech 2011, 45:4702–4709.
40. Razmi A, Barry D, Lemmin U, Bonvin F, Kohn T, Bakhtyar R. Wind and thermal stratification effects on residence and travel times in an open, wide, and deep lacustrine embayment: Vidy Bay (Lake Geneva, Switzerland). Aquat Sci Submitted for publication.
41. Yamamoto H, Nakamura Y, Moriguchi S, Nakamura Y, Honda Y, Tamura I, Hirata Y, Hayashi A, Sekizawa J. Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: laboratory photolysis, biodegradation, and sorption experiments. Water Res 2009, 43:351–362.
42. Bonvin F, Omlin J, Rultler R, Scheizer W, Alaimo P, Strathmann T, McNeill K, Kohn T. Direct photolysis of human metabolites of the antibiotic sulfamethoxazole: evidence for abiotic back-transformation. Environ Sci Tech 2013, 47:9207–9216.
43. Cunningham V. Special characteristics of pharmaceuticals related to environmental fate. In: Kümmerer K, ed. Pharamceuticals in the Environment: Sources, Fate, Effects, and Risks. 3th ed. Berlin, Heidelberg, New York: Springer; 2008, 23–34.
44. European Commission. Technical Guidance Document on Risk Assessment. TGD Part II. 2003. Available at: http://ecb.jrc.it/cgi-bin/reframer.pl?A=ECB&B=/Technical-Guidance-Document/. (Accessed 28 May 2013).
45. Posthuma L, Suter GWI, Traas TP. Species Sensitivity Distribution in Ecotoxicology. Boca Raton, FL: Lewis Publishers; 2002.
46. Ortelli D, Edder P, Rapin F, Ramseier S. Métaux et micropolluants organiques dans les rivières et les eaux du Léman. Rapport de la Commission internationale pour la protection des eaux du Léman contre la pollution 2011; Campagne 2009, 65–86.
47. Steger-Hartmann T, Länge R, Schweinfurth H. Environmental risk assessment of the widely used iodinated X-ray contrast agent iopromide (Ultravist). Ecotoxicol Environ Saf 1999, 42:274–281.
48. Edder P, Ortelli D, Klein A, Ramseier Gentile S. Métaux et micropolluants organiques dans les eaux et les sédiments du Léman. Rapport de la Commission internationale pour la protection des eaux du Léman contre la pollution 2008; Campagne 2007, 57–84.
49. Ortelli D, Edder P, Rapin F, Ramseier S. Métaux et micropolluants organiques dans les eaux du Léman. Rapport de la Commission internationale pour la protection des eaux du Léman contre la pollution 2009; Campagne 2008, 59–71.
50. Tauxe Würsch A. Wastewaters: occurrence of pharmaceutical substances and genotoxicity. PhD Thesis, ENAC, 2005.
51. Schlabach M, Grung M, Heimstad E, Moe M, Svenson A, Thomas KV, Woldegiogis A. Human and veterinary pharmaceuticals, narcotics, and personal care products in the environment; 2005, 98.
52. Bernard M, Arnold C. Micropolluants dans les eaux du Rhône (micropollutants in the water of the river Rhône). Rapport de la Commission internationale pour la Protection des eaux du Léman contre la Pollution 2012; Campagne 2011, 122–138.
53. European Medicines Agency. Guideline for environmental risk assessment of medicinal products for human use. 2006.
54. Boxall A, Rudd MA, Brooks B, Caldwell D, Choi K, Hickmann S, Innes E, Ostapyk K, Staveley J, Verslycke T, et al. Pharmaceuticals and personal care products in the environment: what are the big questions? Environ Health Perspect 2012, 120:1221–1229.
55. Fent K, Weston AA, Camindada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76:122–159.
56. World Health Organization (WHO). Global assessment of the state-of-the-science of endocrine disruptors. Available at: http://www.who.int/ipcs/publications/new_issues/endocrine_disruptors/en/. (Accessed 28 May 2013).
57. Sumpter JP, Jobling S. The occurrence, causes, and consequences of estrogens in the aquatic environment. Environ Toxicol Chem 2013, 32:249–251.
58. Caldwell DJ, Mastrocco F, Anderson PD, Länge R, Sumpter JP. Predicted-no-effect concentrations for the steroid estrogens estrone, 17β-estradiol, estriol, and 17α-ethinylestradiol. Environ Toxicol Chem 2012, 31:1396–1406.
59. Brennan S, Brougham C, Roche J, Fogarty A. Multi-generational effects of four selected environmental oestrogens on Daphnia magna. Chemosphere 2006, 64:49–55.
60. Hannah R, D'Aco VJ, Anderson PD, Buzby ME, Caldwell DJ, Cunningham VL, Ericson JF, Johnson AC, Parke NJ, Samuelian JH, et al. Exposure assessment of 17α-ethinylestradiol in surface waters of the United States and Europe. Environ Toxicol Chem 2009, 28:2725–2732.
61. Buerge IJ, Buser H-R, Poiger T, Müller MD. Occurrence and fate of cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface water. Environ Sci Tech 2006, 40:7242–7250.
62. Johnson AC, Jürgens MD, Williams R, Kümmerer K, Kortenkamp A, Sumpter JP. Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. J Hydrol 2008, 348:167–175.
63. Roberts P, Thomas K. The occurence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Tot Environ 2006, 356:143–153.
64. Borgatta M, Waridel P, Decosterd L, Buclin T, Chèvre N. Acute and chronic effects of tamoxifen on Daphnia pulex: is this anticancer drug teratogenic at environmentally relevant concentrations? Environ Int. Submitted for publication.
65. Kummerer K. Antibiotics in the aquatic environment—a review—Part II. Chemosphere 2009, 75:435–441.
66. Vanneste D, Cornish J, Yu R, Boyd R, Morris C. Isolation of copper and steptomycin resistant phytopathogenic Pseudomonas syringea from lakes and rivers in central north island of New Zealand. NZ Plant Protect 2008, 61:80–85.
67. Schmidt H, Römbke J. The ecotoxicological effects of pharmaceuticals (antibiotics and antiparasiticides) in terrestrial environment—a review. In: Kümmerer K, ed. Pharmaceuticals in the Environment. 3rd ed. Berlin, Heidelberg: Springer; 2008, 285–303.
68. Czekalski N, Berthold T, Caucci S, Egli A, Buergmann H. Increased levels of multiresistant bacteria and resistance genes after wastewater treatment and their dissemination into Lake Geneva, Switzerland. Front Microbiol 2012, doi: 10.3389/fmicb.2012.00106.
69. Ramirez AJ, Brain RA, Usenko S, Mottaleb MA, O'Donnell JG, Stahl LL, Wathen JB, Snyder BD, Pitt JL, Perez-Hurtado P, et al. Occurrence of pharmaceuticals and personal care products in fish: results of a national pilot study in the United States. Environ Toxicol Chem 2009, 28:2587–2597.
70. Taggart MA, Cuthbert R, Das D, Sashikumar C, Pain DJ, Green RE, Feltrer Y, Shultz S, Cunningham AA, Meharg AA. Diclofenac disposition in Indian cow and goat with reference to Gyps vulture population declines. Environ Pollut 2007, 147:60–65.
71. Kümmerer K. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. 3rd ed. Berlin: Springer; 2008.
72. Celiz MD, Tso J, Aga DS. Pharmaceutical metabolites in the environment: analytical challenges and ecological risks. Environ Toxicol Chem 2009, 28:2473–2484.
73. Boxall ABA, Sinclair C, Fenner K, Kolpin D, Maund SJ. When synthetic chemicals degrade in the environment. Environ Sci Tech 2004, 38:369A–375A.
74. Albert A. Chemical aspects of selective toxicity. Nature 1958, 182:421–422.
75. Dahmane E, Mercier T, Zanolari B, Cruchon S, Guignard N, Buclin T, Leyvraz S, Zaman K, Csajka C, Decosterd L. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:3402–3414.
76. Borgatta M, Waridel P, Buclin T, Chèvre N. Are anticancer drug metabolites toxic on Daphnia pulex after chronic exposure? In: 23rd SETAC-Europe Annual Meeting, Glasgow, UK, 12–16 May 2013.
77. Grimme LH, Altenburger R, Backhaus T, Faust M, Bödeker W, Scholze M. Kombinationswirkungen von Umweltchemikalien in der Ökotoxikologie. Z Umweltchem Ökotox 2000, 12:226–234.
78. Backhaus T, Altenburger R, Arrhenius A, Blanck H, Faust M, Finizio A, Gramatica P, Grote M, Junghans M, Meyer W, et al. The BEAM-project: prediction and assessment of mixture toxicities in the aquatic environment. Cont Shelf Res 2003, 23:1757–1769.
79. Silva E, Rajapakse N, Kortenkamp A. Something from “nothing”—eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Tech 2002, 36:1751–1756.
80. Painter MM, Buerkley MA, Julius ML, Vajda AM, Norris DO, Barber LB, Furlong ET, Schultz MM, Schoenfuss HL. Antidepressants at environmentally relevant concentrations affect predator avoidance behavior of larval fathead minnows (Pimephales promelas). Environ Toxicol Chem 2009, 28:2677–2684.
81. Gilroy ÈAM, Balakrishnan VK, Solomon KR, Sverko E, Sibley PK. Behaviour of pharmaceuticals in spiked lake sediments—effects and interactions with benthic invertebrates. Chemosphere 2012, 86:578–584.
82. Miège C, Choubert J, Ribeiro L, Eusèbe M, Coquery M. Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions—conception of a database and first results. Water Sci Technol 2008, 57:49–56.
83. Nakada N, Shinohara H, Murata A, Kiri K, Managaki S, Sato N, Takada H. Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water Res 2007, 41:4373–4382.
84. Kim I, Tanaka H, Iwasaki T, Takubo T, Morioka T, Kato Y. Classification of the degradability of 30 pharmaceuticals in water with ozone, UV and H2O2. Water Sci Technol 2008, 57:195–200.
85. Roswell V, Pang D, Tsafou F, Voulvoulis N. Removal of steroid estrogens from wastewater using granular activated carbon: comparison between virgin and reactivated carbon. Water Environ Res 2009, 81:394–400.
86. Margot J, Rossi L, Kienle C, Magnet A, Weil M, De Alencastro F, Abegglen C, Thonney D, Chèvre N, Schärer M, et al. Treatment of micropollutants in municipal wastewater treatment plants: Ozonation or powdered activated carbon? Conclusions of a long-term real scale pilot project. Sci Tot Environ. Submitted for publication.
87. Kazner C, Lehnberg K, Kovalova L, Wintgens T, Melin T, Hollender J, Dott W. Removal of endocrine disruptors and cytostatics from effluent by nanofiltration in combination with adsorption on powdered activated carbon. Water Sci Technol 2008, 58:1699–1706.
88. Leman21 project. Available at: www.leman21.ch
89. Commission Internationale pour la Protection des Eaux du Léman (CIPEL). Available at: www.cipel.org